Abstract
There is biological evidence for the hypothesis that the frequency of malignant melanoma is influenced by hormonal or reproductive factors. Estrogen receptors have been found in human malignant melanoma cells, though the percent age that are estrogen positive varies considerably by study (Creagan et al. 1980; Fisher et al. 1976). Estrogens and progesterone together or estrogen alone increase the number of melanocytes and the intracellular and extracellular melanin content in guinea pigs (Snell and Bischitz 1960). Ultraviolet light exposure causes darkening of the skin pigment and is believed to play a role in the etiology of melanoma (Holman and Armstrong 1984). Estrogens, whether administered topically (Jadassohn 1958), used to relieve menopausal symptoms (Hamilton 1939), or taken for contraception, can also produce hyperpigmentation, the degree of darkening increasing with duration of use (Carruthers 1966).
The work reported in this paper was supported in part by NCl grants CA 34382 and CA 19408
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsPreview
Unable to display preview. Download preview PDF.
Abbreviations
- MM :
-
malignant melanoma
- SSM :
-
superficial spreading melanoma
- NM :
-
nodular melanoma
- OC :
-
oral contraceptives
References
Adam SA, Sheaves JK, Wright NH, Mosser RW, Vessey MP (1981) A case-control study of the possible association between oral contraceptives and malignant melanoma. Br J Cancer 44: 45–50
Bain C, Hennekens CH, Speizer FE, Rosner B, Willett W, Belanger C (1982) Oral contraceptive use and malignant melanoma. JNC I 68: 537–539
Beral V, Ramcharan S, Faris R (1977) Malignant melanoma and oral contraceptive use among women in California. Br J Cancer 36: 804–809
Beral V, Evans S, Shaw H, Milton G (1984) Oral contraceptive use and malignant melanoma in Australia. Br J Cancer 50: 681–685
Carruthers R (1966) Chloasma and oral contraceptives. Med J Aust 2: 17–20
Creagan ET, Ingle JN, Woods JE, Pritchard DJ, Jiang NS (1980) Estrogen receptors in patients with malignant melanoma. Cancer 46: 1785–1786
Fisher RI, Neifeld JP, Lippman ME (1976) Oestrogen receptors in human malignant melanoma. Lancet 2: 337–338
Gallagher RP, Elwood JM, Hill GB, Coldman AJ, Threlfall WJ, Spinelli JJ (1985) Reproductive factors, oral contraceptives and risk of malignant melanoma: Western Canada melanoma study. Br J Cancer 52: 901–907
Hamilton JB (1939) Significance of sex hormones in tanning of the skin of women. Proc Soc Exp Biol Med 40: 402–503
Heimrich SP, Rosenberg L, Kaufman DW, Miller DR, Schottenfeld D, Stolley PD, Shapiro S (1984) Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use. JNCI 72: 617–620
Holly EA, Weiss NS, Liff JM (1983) Cutaneous melanoma in relation to exogenous hormones and reproductive factors. JNCI 70: 827–831
Holman CDJ, Armstrong BK (1984) Cutaneous malignant melanoma and indicators of total accumulated exposure to the sun: an analysis separating histogenetic types. JNCI 73: 75–82
Holman CDJ, Armstrong BK, Heenan PJ (1984) Cutaneous malignant melanoma in women: exogenous sex hormones and reproductive factors. Br J Cancer 50: 673–680
Hoover R, Bain C, Cole P, MacMahon B (1978) Oral contraceptive use: association with frequency of hospitalization and chronic disease risk indicators. Am J Public Health 68: 335–341
Jadassohn W (1958) Art for art’s sake in medicine. Arch Dermatol 78: 427–437
Kay CR (1981) (letter) Malignant melanoma and oral contraceptives. Br J Cancer 44: 479
Ramcharan S, Pellegrin FA, Ray R, Hsu JP (1981) The Walnut Creek contraceptive drug study. A prospective study of the side effects of oral contraceptives, vol III. US Government Printing Office, Washington D.C.
Siegel S (1956) Nonparametric statistics. McGraw-Hill, New York, pp 68–75
Snell RS, Bischitz PG (1960) The effect of large doses of estrogen and estrogen and progesterone on melanin pigmentation. J Invest Dermatol 35: 73–82
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1986 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Holly, E.A. (1986). Cutaneous Melanoma and Oral Contraceptives: A Review of Case-Control and Cohort Studies. In: Gallagher, R.P. (eds) Epidemiology of Malignant Melanoma. Recent Results in Cancer Research, vol 102. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-82641-2_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-82641-2_8
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-82643-6
Online ISBN: 978-3-642-82641-2
eBook Packages: Springer Book Archive